Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Analgesic Safety Campaign Launches; Label Warnings Still In Progress

This article was originally published in The Tan Sheet

Executive Summary

FDA launched a public educational campaign Jan. 22 warning consumers about the link between acetaminophen and liver damage, and potential renal and gastrointestinal problems associated with nonsteroidal anti-inflammatory use
Advertisement

Related Content

FDA Proposes Liver, GI Risk Warnings For OTC Pain Relievers
FDA Proposes Liver, GI Risk Warnings For OTC Pain Relievers
FDA Proposes Liver, GI Risk Warnings For OTC Pain Relievers
FDA promotes OTC safety
FDA promotes OTC safety
FDA promotes OTC safety
FDA, NCL Launch “Take With Care” OTC Analgesic Safety Campaign
Nasal Decongestants Monograph Amendment On Sinusitis Claims Planned
Aspirin, NSAID GI Bleeding Language Could Replace Alcohol Warning
Aspirin, NSAID GI Bleeding Language Could Replace Alcohol Warning

Topics

Advertisement
UsernamePublicRestriction

Register

PS096395

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel